ARTICLE | Clinical News
BF-Derm1: Completed Phase II enrollment
December 8, 2008 8:00 AM UTC
Biofrontera completed enrollment of 51 patients in the placebo-controlled portion of a German and Russian Phase II trial evaluating BF-Derm1 for 8 weeks. ...